About
We exist because
13 people die
every day.
That is the number of Americans who die daily waiting for a kidney transplant. Not because the science is impossible. Because the science is fragmented. Spark Kidney was built to change that.
The Mission
Build the intelligence layer
that grows the first kidney.
Spark Kidney is the AI-powered integration platform for the synthetic organ field. We are not a lab, not a device company, and not a research institution. We are the entity that connects 50 isolated labs, six unsolved stacks of science, and two million patients into a manufacturable solution.
The model is simple: labs contribute data to a federated AI mesh. The mesh generates predictions no single lab can make alone. Those predictions shorten the timeline to the first working kidney by years. And when the recipe is proven, Spark becomes the factory.
Integration over invention.
The world does not need another kidney research lab. It needs a company that makes the 50 that exist work together. We build the bridge, not the island.
Data is infrastructure.
Every breakthrough in biology is downstream of someone connecting two datasets that had never been connected before. We build the connection layer first.
Speed is moral.
Thirteen people die every day waiting for a kidney. Every month the field stays fragmented is not an abstraction. We move with urgency because the math demands it.
The story shapes reality.
SpaceX did not just build rockets. It changed what people believed was possible. Spark does the same for synthetic organs. The narrative is part of the product.
The Founder
Corwin Carr
Founder and CEO
The blueprint for Spark Kidney starts from a single observation: the synthetic organ field has the same structure as the early AI field. Hundreds of brilliant researchers solving pieces of a problem in isolation. No shared compute. No shared data. No shared infrastructure. And then OpenAI arrived and unified it.
Spark is the OpenAI moment for synthetic organs. The company that builds the platform the entire field runs on, accumulates the data advantage that cannot be replicated, and ultimately produces the product itself.
The kidney is the opening move. The architecture scales to every organ the body grows.
How We Operate
We do not replicate science that already exists. We connect it.
We treat academic partners as co-builders, not vendors.
We own the data layer. Labs keep their IP.
We publish landmark science that no single lab could produce alone.
We build the regulatory pathway while we build the platform.
We hire people who are embarrassed by what is considered impossible.
The team is being
built right now.
We are looking for engineers who want to solve the hardest data problem in biology, researchers who are frustrated by how siloed the field is, and investors who understand what a platform company in this space is worth.